The genome of the blood fluke Schistosoma mansoni.

TitleThe genome of the blood fluke Schistosoma mansoni.
Publication TypeJournal Articles
Year of Publication2009
AuthorsBerriman M, Haas BJ, LoVerde PT, R Wilson A, Dillon GP, Cerqueira GC, Mashiyama ST, Al-Lazikani B, Andrade LF, Ashton PD, Aslett MA, Bartholomeu DC, Blandin G, Caffrey CR, Coghlan A, Coulson R, Day TA, Delcher A, DeMarco R, Djikeng A, Eyre T, Gamble JA, Ghedin E, Gu Y, Hertz-Fowler C, Hirai H, Hirai Y, Houston R, Ivens A, Johnston DA, Lacerda D, Macedo CD, McVeigh P, Ning Z, Oliveira G, Overington JP, Parkhill J, Pertea M, Pierce RJ, Protasio AV, Quail MA, le Rajandream M-A, Rogers J, Sajid M, Salzberg SL, Stanke M, Tivey AR, White O, Williams DL, Wortman J, Wu W, Zamanian M, Zerlotini A, Fraser-Liggett CM, Barrell BG, El-Sayed NM
JournalNature
Volume460
Issue7253
Pagination352-8
Date Published2009 Jul 16
ISSN1476-4687
KeywordsAnimals, Biological Evolution, Exons, Genes, Helminth, Genome, Helminth, Host-Parasite Interactions, Introns, Molecular Sequence Data, Physical Chromosome Mapping, Schistosoma mansoni, Schistosomiasis mansoni
Abstract

Schistosoma mansoni is responsible for the neglected tropical disease schistosomiasis that affects 210 million people in 76 countries. Here we present analysis of the 363 megabase nuclear genome of the blood fluke. It encodes at least 11,809 genes, with an unusual intron size distribution, and new families of micro-exon genes that undergo frequent alternative splicing. As the first sequenced flatworm, and a representative of the Lophotrochozoa, it offers insights into early events in the evolution of the animals, including the development of a body pattern with bilateral symmetry, and the development of tissues into organs. Our analysis has been informed by the need to find new drug targets. The deficits in lipid metabolism that make schistosomes dependent on the host are revealed, and the identification of membrane receptors, ion channels and more than 300 proteases provide new insights into the biology of the life cycle and new targets. Bioinformatics approaches have identified metabolic chokepoints, and a chemogenomic screen has pinpointed schistosome proteins for which existing drugs may be active. The information generated provides an invaluable resource for the research community to develop much needed new control tools for the treatment and eradication of this important and neglected disease.

DOI10.1038/nature08160
Alternate JournalNature
PubMed ID19606141
PubMed Central IDPMC2756445
Grant List086151 / / Wellcome Trust / United Kingdom
5D43TW006580 / TW / FIC NIH HHS / United States
5D43TW007012-03 / TW / FIC NIH HHS / United States
AI054711-01A2 / AI / NIAID NIH HHS / United States
AI48828 / AI / NIAID NIH HHS / United States
R01 GM083873 / GM / NIGMS NIH HHS / United States
R01 GM083873-07 / GM / NIGMS NIH HHS / United States
R01 GM083873-08 / GM / NIGMS NIH HHS / United States
R01 LM006845 / LM / NLM NIH HHS / United States
R01 LM006845-08 / LM / NLM NIH HHS / United States
R01 LM006845-09 / LM / NLM NIH HHS / United States
U01 AI048828 / AI / NIAID NIH HHS / United States
U01 AI048828-01 / AI / NIAID NIH HHS / United States
U01 AI048828-02 / AI / NIAID NIH HHS / United States
WT085775/Z/08/Z / / Wellcome Trust / United Kingdom